Health Condition 1: J168- Pneumonia due to other specified infectious organisms
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Homi Bhabha Cancer Hospital & Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pediatric or adult hematolymphoid cancer patients. 2. Among pediatric population, patient with age group of 1-14 years will be included in the study 3. Patient with febrile neutropenia despite of appropriate antibiotic treatment for more than 4 days with positive galactomannan assay with/without radiological finding suggestive of fungal pneumonia. OR Febrile neutropenic patient with clinical suspiciousness for fungal pneumonia and consistent with radiological finding towards fungal pneumonia
Exclusion criteria
Exclusion criteria: 1. Pediatric patient with age of less than or equal to 1 year 2. Patient with negative galactomannan assay and radiological imaging not suggesting fungal pneumonia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Diagnostic performance of Galactomannan assay. 2)Analysis of associated risk factors for Invasive aspergillosis in adult and pediatric hemato-lymphoid cancer populationTimepoint: 1)Within 10 days of enrollment in the study 2)Within 10 days of enrollment in the study On the day of enrollment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Analysis of available diagnostic criteria (EORTC and Asp ICU) for IA among cancer population.Timepoint: 1)Within 10 days of enrollment in the study | — |
Countries
India
Contacts
Public ContactDr Anmol Singh
MPMMCC and HBCH, Tata Memorial Centre
Outcome results
None listed